Zhang N, Liu T, Wang J, Xiao Y, Zhang Y, Dai J, . . . Ma D. (2023). Si-Ni-San Reduces Hepatic Lipid Deposition in Rats with Metabolic Associated Fatty Liver Disease by AMPK/SIRT1 Pathway. Dove Medical Press.
Chicago Style (17th ed.) CitationZhang N, Liu T, Wang J, Xiao Y, Zhang Y, Dai J, Ma Z, and Ma D. Si-Ni-San Reduces Hepatic Lipid Deposition in Rats with Metabolic Associated Fatty Liver Disease by AMPK/SIRT1 Pathway. Dove Medical Press, 2023.
MLA (9th ed.) CitationZhang N, et al. Si-Ni-San Reduces Hepatic Lipid Deposition in Rats with Metabolic Associated Fatty Liver Disease by AMPK/SIRT1 Pathway. Dove Medical Press, 2023.
Warning: These citations may not always be 100% accurate.